Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1721
-
1722
-
1723
-
1724
-
1725
-
1726
Repeated WAS decreased expression of H<sub>2</sub>S-producing enzymes.
Published 2013“…F: Summarized results showing that WAS decreased the expression of H<sub>2</sub>S-producing enzymes. …”
-
1727
Mice deficient for <i>Asxl2</i> have decreased BMD.
Published 2011“…(B) Female mice deficient in <i>Asxl2</i> (−/−) display significant decreases relative to wild-type controls (+/+) in (D) TBMD, (E) SBMD and (F) FBMD residuals after adjusted for age and body weight. …”
-
1728
The Hh signaling pathway effectors are decreased in E14.5 <i>Fuz<sup>−/−</sup></i> mouse embryos.
Published 2013“…<b>C</b>) Immunofluorescence of Gli2 in sagittal sections of E14.5 <i>Fuz<sup>+/−</sup></i> heterozygous embryos. …”
-
1729
-
1730
-
1731
-
1732
-
1733
-
1734
-
1735
Progesterone decreased LPS-induced iNOS and COX-2 expression.
Published 2014“…(A) Representative immunoblots demonstrate time course changes for iNOS, COX-2 and GAPDH with LPS (30 ng/ml) stimulation. (B) Pretreatment of progesterone for 1 h dose-dependently decreased LPS (30 ng/ml, 4 h)-stimulated iNOS and COX-2 expression. …”
-
1736
-
1737
Zoledronate treatment resulted in decreased expression of VEGF and downregulation of eNOS, Akt and MMP-9 activities in ischemic tissue.
Published 2013“…High-dose zolendronate significantly downregulated eNOS activity in ischemic muscle (*p<0.05 compared to control), and decreased Akt activity both in low-dose and high-dose regimens (*p<0.05, **p<0.05 compared to control). …”
-
1738
-
1739
-
1740
PARP-1 inhibition decreases atherogenic index in ApoE<sup>−/−</sup> mice on HF diet for 16 weeks.
Published 2009“…Though HF diet significantly decreased HDL-cholesterol in DKO mice, atherogenic index still remained significantly higher in ApoE<sup>−/−</sup> mice than DKO mice (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007430#pone-0007430-g002" target="_blank">Figure 2D</a>). …”